RIEGER JAYSON (CEO and President) purchased 13.7% of their position (25K shares) of VERRICA PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $125.7K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/18/2026ACC: 0002043558-26-000005
DirectorOfficer· CEO and President
Since Nov 2024
+25K
Net shares
Net buyer
$125.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
25K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
$5.06
Trade value
$101.20K
% of position
11.0%
8/14/2026
182.59K→202.59K
Common Stock
Direct
Shares
+5K
Price / share
$4.91
Trade value
$24.55K
% of position
2.5%
8/17/2026
202.59K→207.59K
Total
Net shares
+25K
Net value
$125.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2026 | P · Purchase | +20K | $5.06 | $101.20K | 11.0% | 182.59K | 202.59K |
| Common Stock Direct | 8/17/2026 | P · Purchase | +5K | $4.91 | $24.55K | 2.5% | 202.59K | 207.59K |
| Total | +25K | $125.75K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned230.00
Common Stock
IndirectShares owned15.00
Common Stock
IndirectShares owned230.00
Common Stock
IndirectShares owned230.00
Total
705.00 indirect705.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 230.00 | Indirect |
| Common Stock | 15.00 | Indirect |
| Common Stock | 230.00 | Indirect |
| Common Stock | 230.00 | Indirect |
| Total | 705.00 | 705.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported